CPhI Online

- Biopharma News

Indian authority extends comments deadline for API anti-dumping probe

19 Nov 2020

India’s Directorate General of Trade Remedies (DGTR) has extended the deadline for companies importing or exporting active pharmaceutical ingredients (APIs) to file responses to an investigation it launched in September over allegations of dumping by Chinese importers of Ceftriaxone Sodium Sterile.

Respondents now have until 11 December 2020 to submit their comments to the DGTR, the Ministry of Commerce and Industry’s investigation unit.

The investigation started after domestic producers Nectar Lifesciences and Sterile India filed a complaint.

According to a DGTR notification dated 24th September, the applicants contended that “material injury” is being caused to India’s domestic industry due to dumped imports of Ceftriaxone Sodium Sterile from China and they requested the imposition of an anti-dumping duty.

In international trade, dumping refers to the practice of exporting a product at a price lower in the foreign importing market than the price in the exporter's domestic market.

The DGTR said it had initiated the probe “to determine the existence, degree and effect of any alleged dumping in respect of the subject goods originating in or exported from [China] and to recommend the amount of anti-dumping duty, which if levied, would be adequate to remove the injury to the domestic industry.”

Ceftriaxone Sodium Sterile is an API used for formulation for treating diseases such as lower respiratory tract infection, skin and skin structure infection, pelvic inflammatory disease, intra-abdominal infection, uncomplicated gonorrhoea infection, and surgical prophylaxis.

While Ceftriaxone Sodium Sterile does not have a dedicated customs classification and is imported into India under numerous Harmonised System codes, the companies have contended that the material arriving from China is identical to that manufactured domestically.

The current investigation covers the periods from 1st April 2019 to 31st March 2O2O (12 months) but it will also study data from the previous three-year period.

Related Content